Abstract
The use of ibrutinib for the treatment of chronic lymphocytic leukemia (CLL) and other hematologic malignancies is blooming. Atrial fibrillation is a ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
